Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. | Chief Business Officer | Common Stock | 19K | $570K | $30.05 | Mar 2, 2023 | Direct |
Kymera Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 63.3K | Mar 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYMR | Kymera Therapeutics, Inc. | Mar 1, 2023 | 4 | -$22.1K | 4 | Mar 3, 2023 | Chief Business Officer |
KYMR | Kymera Therapeutics, Inc. | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | Chief Business Officer |
KYMR | Kymera Therapeutics, Inc. | Jun 21, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Chief Business Officer |
KYMR | Kymera Therapeutics, Inc. | Jun 21, 2021 | 0 | $0 | 3 | Jun 21, 2021 | Chief Business Officer |